Improving VTE Risk Assessment: Education and Prophylaxis in Rural Cancer Clinics

Authors

Heather M. Feldman, University of Vermont Cancer Center, University of Vermont, Burlington, Vermont, USA.
Eswar Tipirneni, Texas Oncology, San Antonio, Texas, USA
Shamima Khan, Division of Public Health, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA
Steven Ades, Division of Hematology and Oncology, University of Vermont Cancer Center, University of Vermont, Burlington, Vermont, USA.
Allison Holm, Data Management Office, University of Vermont Health Network, Burlington, Vermont, USA.
Chris E. Holmes, Division of Hematology and Oncology, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.

Files

Why this matters?

•Cancer-associated thrombosis (CAT) is the second leading cause of death in patients with cancer and is preventable •Venous thromboembolism (VTE) risk assessment and preventative treatment in high-risk patients who are at low risk of bleeding are recommended for outpatients with cancer initiating therapy

Publication Date

3-2025

Disciplines

Community Health | Oncology

Comments

This work was supported by the National Institutes of Health [U54 GM115516] for the Northern New England Clinical and Translational Research Network.